-
Mashup Score: 0Hair Regrowth in Severe Alopecia Areata Improves Quality of Life While Reducing Anxiety, Depression - 1 year(s) ago
People with alopecia areata who experience hair regrowth may also see improvements in their quality of life and mental health, according to a new study.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
Source: www.jaad.orgCategories: Dermatology, Latest HeadlinesTweet-
Read the special supplement today! https://t.co/0YgLBjFyLh @JAADjournals #JAAD #AlopeciaAreata #Alopecia #Hair #Treatments https://t.co/cZ8ZGciJ5z
-
-
Mashup Score: 1Janus kinase inhibitors for alopecia areata - 1 year(s) ago
Janus kinase (JAK) inhibitors have ushered in a new era in alopecia areata (AA). Historically, moderate-to-severe AA was refractory to treatment. JAK inhibitors have changed that; now, treatment of moderate-to-severe AA is possible. Here, we briefly review the history of and rationale for JAK inhibitor treatment of AA, phase 3 clinical trial data, and considerations regarding differences among JAK inhibitors, safety, and patient selection.
Source: www.jaad.orgCategories: Latest Headlines, Partners & KOLsTweet-
Janus kinase (JAK) inhibitors have ushered in a new era in #alopeciaareata (AA). Historically, moderate-to-severe AA was refractory to treatment. JAK inhibitors have changed that; now, treatment of AA is possible. https://t.co/cUq0CWdfdV @Brett_King_ @dermdoctorbritt https://t.co/XWcIYrhRfU
-
-
Mashup Score: 1
The distribution of eyebrow and eyelash hair loss in relation to the severity of scalp hair loss remains underexplored, and this study established baseline characteristics.
Source: www.dermatologytimes.comCategories: Dermatology, Latest HeadlinesTweet-
Research presented at @MauiDerm NP+PA 2023 reveals the broader impact of #AlopeciaAreata, extending beyond scalp hair loss to include eyebrow and eyelash hair, significantly affecting patients' well-being. #HairLossResearch https://t.co/1KsgQaVkaE
-
-
Mashup Score: 24
AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
Source: www.jaad.orgCategories: Latest Headlines, Partners & KOLsTweet-
RT @ELS_Dermatology: Read the special supplement today! https://t.co/oDShJDuf3u @JAADjournals #JAAD #AlopeciaAreata #Alopecia #Hair #Treat…
-
-
Mashup Score: 0AAD.org Login - 1 year(s) ago
Create a non-member account if you are applying for m embership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our
Source: identity.aad.orgCategories: Dermatology, Latest HeadlinesTweet-
.@TheJEADV study assessed whether exposure to biologics for women with psoriasis is associated with an elevated risk of congenital malformation or miscarriage. Learn more in #DermWorldWeekly - https://t.co/vB2tRsAyui https://t.co/GWd6QzDK6W
-
A @JAADJournals research letter suggests a significant relationship for #atopicdermatitis contributing to the occurrence of #alopeciaareata. Learn more in #DermWorldWeekly - https://t.co/EqM4iTGZyM
-
-
Mashup Score: 0Severe Alopecia Areata Patients Without Regrowth of Scalp Hair Benefit from Dose Increase of Baricitinib - 1 year(s) ago
This new data may need to be examined by health providers when they advise patients about treatment outcomes for increasing dosage, including those who could benefit from a higher dose of baricitinib.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
This new research may aid health providers in advising patients on outcomes for those who could benefit from a higher dose of #baricitinib: https://t.co/anLd1UOQw7 #AlopeciaAreata #dermtwitter
-
-
Mashup Score: 0Ahmad Amin, MD: Effects of the FDA Approval of Ritlecitinib for Adolescents with Alopecia Areata - 2 year(s) ago
In his interview, Dr. Amin discusses his views on the FDA’s recent approval of ritlecitinib for the treatment of adolescent patients with alopecia areata.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
In this interview, Dr. Ahman Amin discusses his views on the FDA’s recent approval of ritlecitinib for the treatment of adolescent patients with #AlopeciaAreata. https://t.co/Nvfp47fsdH #Alopecia
-
-
Mashup Score: 0Venous Thromboembolism Risk in Patients With Alopecia Areata - 2 year(s) ago
Researchers aimed to assess the risk of venous thromboembolism in patients with alopecia areata.
Source: www.hmpgloballearningnetwork.comCategories: Dermatology, Latest HeadlinesTweet-
According to a study published in Dermatology and Therapy, alopecia areata may be associated with an increased risk of venous thromboembolism. Read More: https://t.co/cWxKodABhF #dermtwitter #dermatologist #dermatology #alopeciaareata #aa #VT #venousthromboembolism
-
-
Mashup Score: 0Ahmad Amin, MD: Effects of the FDA Approval of Ritlecitinib for Adolescents with Alopecia Areata - 2 year(s) ago
In his interview, Dr. Amin discusses his views on the FDA’s recent approval of ritlecitinib for the treatment of adolescent patients with alopecia areata.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In this interview, Dr. Ahmad Amin discusses his views on the @US_FDA's recent approval of ritlecitinib for the treatment of adolescents with #AlopeciaAreata. View the interview clip here: https://t.co/Dwqk2LN6vl
-
People with #AlopeciaAreata who experience hair regrowth may also see improvements in their quality of life and mental health, according to a new study. Learn more: https://t.co/iGfwbhRWxw https://t.co/OgukW4LTOq